< BACK TO NEWS
positiveSYS.SOURCE: Ars Technica• 2026-10-25T19:29:16Z

Moderna and Merck's Personalized mRNA Cancer Vaccine Demonstrates 42% Reduction in Mortality and Recurrence

Moderna and Merck's personalized mRNA cancer vaccine demonstrated a 42% reduction in mortality and recurrence among melanoma patients. The trial highlights the potential of mRNA-based immunotherapies in oncology treatment strategies.

Comments

Read original article

*** END OF TRANSMISSION ***

> MODERNA AND MERCK'S PERSONALIZED MRNA CANCER VACCINE DEMONSTRATES 42% REDUCTION IN MORTALITY AND RECURRENCE> DOLLY PARTON'S IMAGINATION LIBRARY: GLOBAL LITERACY INITIATIVE> REIMAGINING OBSERVABILITY: THE CASE FOR WIDE EVENTS OVER TRADITIONAL METRICS, LOGS, AND TRACES> OREGON POLICE IMPOSE $2.5M FEE FOR PUBLIC RECORDS REQUEST ON OFFICER MISCONDUCT CASE> CRITICAL UNPATCHED TAILSCALE SSH VULNERABILITIES ENABLE PRIVILEGE ESCALATION ACROSS NETWORKS> DIGITAL DISSIDENT DEVROOM AT FOSDEM 27: COMBATING INTERNET CENSORSHIP THROUGH COLLABORATIVE TOOL DEVELOPMENT> CRITIQUE OF EXCESSIVE NUANCE IN SOCIOLOGICAL THEORY> RECREATION OF ANCIENT ROMAN DICHROIC GLASS TECHNOLOGY BY UNIVERSITY OF SHEFFIELD RESEARCHERS> AI-ASSISTED PHP2SHELL EXPLOITATION TARGETS EUROPEAN GOVERNMENT ENTITY> OLDER CNN OUTPERFORMS STATE-OF-THE-ART LLMS IN SKIN CANCER DIAGNOSIS> MODERNA AND MERCK'S PERSONALIZED MRNA CANCER VACCINE DEMONSTRATES 42% REDUCTION IN MORTALITY AND RECURRENCE> DOLLY PARTON'S IMAGINATION LIBRARY: GLOBAL LITERACY INITIATIVE> REIMAGINING OBSERVABILITY: THE CASE FOR WIDE EVENTS OVER TRADITIONAL METRICS, LOGS, AND TRACES> OREGON POLICE IMPOSE $2.5M FEE FOR PUBLIC RECORDS REQUEST ON OFFICER MISCONDUCT CASE> CRITICAL UNPATCHED TAILSCALE SSH VULNERABILITIES ENABLE PRIVILEGE ESCALATION ACROSS NETWORKS> DIGITAL DISSIDENT DEVROOM AT FOSDEM 27: COMBATING INTERNET CENSORSHIP THROUGH COLLABORATIVE TOOL DEVELOPMENT> CRITIQUE OF EXCESSIVE NUANCE IN SOCIOLOGICAL THEORY> RECREATION OF ANCIENT ROMAN DICHROIC GLASS TECHNOLOGY BY UNIVERSITY OF SHEFFIELD RESEARCHERS> AI-ASSISTED PHP2SHELL EXPLOITATION TARGETS EUROPEAN GOVERNMENT ENTITY> OLDER CNN OUTPERFORMS STATE-OF-THE-ART LLMS IN SKIN CANCER DIAGNOSIS